Jul 17, 2025
Bladder cancer is one of the most common malignancies of the urinary system. Radical cystectomy remains the golden standard for treating muscle-invasive bladder cancer, yet it is considered one of the most complex and demanding procedures in urologic surgery. The main challenges include intricate pelvic anatomy, dense distribution of vital vessels and nerves, high risk of bleeding or rectal injury, extensive surgical scope requiring en bloc removal of the bladder and prostate, iliac lymphadenectomy, and complex urinary diversion with significant postoperative complications--all of which severely impact surgical outcomes and patient recovery.
With the advancement of minimally invasive techniques such as laparoscopy and cystoscopy, these challenges are gradually being overcome. Leading experts like Professor Zhang Zheng’s team at Peking University First Hospital have demonstrated mature surgical capabilities. During radical cystectomy, Prof. Zhang frequency employs the AGISEAL SL0844 instrument to efficiency and safely manage lateral bladder pedicles and pelvic lymph mode dissection. AGISEAL enables direct coagulation of deep vascular networks--including the dorsal vein complex--avoiding the limited visibility and complexity associated with traditional suturing. This reduces the need for perioperative transfusions and minimizes secondary pelvic bleeding. Additionally, AGISEAL enables rapid and effective handling of obturator vessels, significantly improving surgical efficiency and reducing operative time. With no foreign material left behind, it supports better postoperative recovery and demonstrates strong clinical performance. As a result, AGISEAL has become a preferred energy device in complex urologic procedures.
Proven across multiple cases, AGISEAL is well-suited for the demands of urologic surgery and serves as a reliable tool in high-difficulty radical cystectomy for bladder cancer.
Read More
IPv6 network supported
中文
